News
Pharma firms will face 15% tariffs in Trump’s E.U. trade deal
WASHINGTON — President Trump’s tariffs on pharmaceuticals coming from the European Union will be set at 15% and will not go into effect until a national security investigation has been completed, according to a White House official familiar with the plans.
Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S.
Topline President Donald Trump suggested Tuesday his administration intends to impose a 200% tariff rate on pharmaceutical imports into the U.S., which would take effect in a year, a major fee ...
An EU pharma lobby has criticized the Trump administration’s plans to impose 15% tariffs on pharmaceutical imports amid uncertainty over how the newly announced U.S.-EU trade deal targets the product ...
Hosted on MSN22d
Trump says he will impose 50% tariff on copper importsHe did not say specifically when that tariff would take effect. Trump also said he would soon announce tariffs "at a very, very high rate, like 200%," on pharmaceutical imports.
The 15 percent tariff rate agreed under the new deal could significantly impact pharma firms reliant on European imports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback